Momenta Pharma (MNTA) Stock Analyst Ratings
NASDAQ:MNTA - Nasdaq -
ChartMill assigns a Buy % Consensus number of 69% to MNTA. The Buy consensus is the weighted average rating of the current analysts ratings.
MNTA was analyzed by 9 analysts. The buy percentage consensus is at 69. So analysts seem to be have mildly positive about MNTA.
In the previous month the buy percentage consensus was at a similar level.
MNTA was analyzed by 9 analysts. More opinions would make the average more meaningful.